PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China · Delayed Price · Currency is CNY

45.49

+1.09 (2.45%)

At close: May 12, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drug Discovery		316.57M	293.21M	274.73M	234.89M	132.39M
Drug Discovery Growth		7.97%	6.73%	16.96%	77.42%	43.62%
Commercial Production		165.21M	109.40M	117.09M	118.72M	113.86M
Commercial Production Growth		51.02%	-6.57%	-1.37%	4.26%	-1.81%
Process Research and Development		48.16M	77.87M	80.31M	92.83M	32.24M
Process Research and Development Growth		-38.15%	-3.04%	-13.49%	187.90%	-6.15%
Unallocated Others		14.52M	9.24M	6.76M	1.77M	-
Unallocated Others Growth		57.21%	36.64%	281.02%	-	-
Total		544.47M	489.72M	478.88M	448.21M	278.50M
Total Growth		11.18%	2.26%	6.84%	60.94%	14.84%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		136.62M	147.80M	140.37M	134.43M	59.78M
China Growth		-7.57%	5.30%	4.42%	124.86%	31.67%
Foreign		407.85M	341.92M	338.52M	313.79M	47.07M
Foreign Growth		19.28%	1.00%	7.88%	566.68%	14.92%
USA		-	-	-	-	111.26M
USA Growth		-	-	-	-	19.42%
India		-	-	-	-	60.39M
India Growth		-	-	-	-	-4.10%
Total		544.47M	489.72M	478.88M	448.21M	278.50M
Total Growth		11.18%	2.26%	6.84%	60.94%	14.84%

Source: S&P Global Market Intelligence.